… “Parkinson’s disease (PD) is a complex condition. It’s complex to diagnose and complex to handle in, oh, so many ways. It’s … impact of the Edmond J. Safra Fellowship in Movement Disorders , a global program focused on increasing the number …

… Michael J. Fox Foundation (MJFF) helps companies overcome early development barriers, strengthening the therapeutics … said Shalini Padmanabhan, PhD, head of translational research at MJFF. “When we reduce early uncertainty, we help … and momentum needed to advance promising therapies into well-designed clinical trials and, ultimately, closer …

… Read on to learn how Bruce has turned fear and uncertainty into action that can help make a world without Parkinson's a reality. For people who receive a Parkinson's diagnosis, thinking about the future can be frightening. … becoming part of MJFF's Legacy Circle and support critical research toward a cure for Parkinson's disease. The Michael …

… has focused on the use of mass spectrometry to identify early biomarkers for PD in CSF and plasma from biobanks of … better in clinical trials if subjects are stratified into subgroups based on distinct molecular profiles. He is currently leading research focused on metabolomic and proteomic identification …

… (KAIST) and Stanford (PhD, Applied Physics), he has led research at the intersection of nanotechnology and … ultrasensitive, noninvasive diagnostic platforms for early detection of Parkinson’s and related … partners, he is committed to translating these technologies into widely accessible tools that transform clinical care …